Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-24 @ 10:35 PM
NCT ID:
NCT05609435
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of stage I, ER and/or PR positive, her2neu negative breast cancer within the last 6-24 monoths
* Willing to complete study procedures using email
Exclusion Criteria:
* Receipt of chemotherapy for the stage I ER and/or PR positive, her2neu negative breast cancer diagnosed within the last 6-24 months
* Participants will be excluded if they are unable to read and write in English or if, in the opinion of a treating clinician, have cognitive impairment that would prevent completion of study procedures
* Pregnancy, based on patient self-report. If a patient becomes pregnant during the study period, they will be removed from the study at that time.
* Diagnosis of a ER and PR negative, her2neu negative breast cancer or a her2neu positive breast cancer within the last 5 years
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
95 Years
Study:
NCT05609435
Study Brief:
Protocol Section:
NCT05609435